Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/1996
09/24/1996US5559153 Antiarrhythmia agents; cardiovascular disorders
09/24/1996US5559143 Anxiolytics, antidepressants, hypotensive agents, treatment of migraine
09/24/1996US5559139 Antiischemic agents, microcirculation
09/24/1996US5559130 Pyrrolidinyl pyridones for treating pain
09/24/1996US5559123 Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
09/24/1996US5559122 Hindered N-oxide esters of rapamycin
09/24/1996US5559111 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
09/24/1996US5559106 Heterocyclic compounds, their use and preparation
09/24/1996US5559094 AspB1 insulin analogs
09/24/1996CA2026418C Polypeptides useful as blockers of calcium channels
09/22/1996CA2172111A1 Nanosuspensions for intravenous administration
09/22/1996CA2172110A1 Pharmaceutical carriers for nanosuspensions
09/19/1996WO1996028730A1 Method of identifying molecules that regulate fgf activity
09/19/1996WO1996028553A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy
09/19/1996WO1996028544A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
09/19/1996WO1996028467A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
09/19/1996WO1996028462A1 17-difluoromethylene-oestratrienes
09/19/1996WO1996028448A1 6-ARYL PYRAZOLO[3,4-d]PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF
09/19/1996WO1996028446A1 SUBSTITUTED N-CYCLOALKYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4 AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF
09/19/1996WO1996028429A1 6-SUBSTITUTED PYRAZOLO [3,4-d] PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF
09/19/1996WO1996028424A1 Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity
09/19/1996WO1996028185A2 Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor
09/19/1996WO1996028178A1 Polyphenol fractions of tea, the use thereof and formulations containing them
09/19/1996WO1996028163A1 Adenosine as a positive inotrop in the compromised heart
09/19/1996WO1996028159A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF
09/19/1996WO1996028152A1 Novel benzofuran pharmaceutical compounds
09/19/1996WO1996028151A2 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs
09/19/1996WO1996028146A1 Novel naphthyl pharmaceutical compounds
09/19/1996WO1996028142A1 Method and kit for preventing erectile dysfunction
09/19/1996WO1996028114A1 Antioxidant-induced apoptosis in vascular smooth muscle cells
09/19/1996DE19509729A1 17-Difluormethylen-Estratriene 17-difluoromethylene estratrienes
09/19/1996CA2215391A1 Method of identifying molecules that regulate fgf activity
09/19/1996CA2215307A1 Pharmaceutical compositions and kits for preventing erectile dysfunction
09/19/1996CA2215201A1 17-difluoromethylene-estratrienes
09/19/1996CA2214823A1 Antioxidant-induced apoptosis in vascular smooth muscle cells
09/19/1996CA2214799A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
09/19/1996CA2214450A1 Novel benzofuran pharmaceutical compounds
09/19/1996CA2214416A1 Novel naphthyl pharmaceutical compounds
09/19/1996CA2214010A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy
09/19/1996CA2213749A1 Adenosine as a positive inotrop in the compromised heart
09/19/1996CA2211729A1 6-aryl pyrazolo[3,4-d¦pyrimidin-4-ones and compositions and methods of use thereof
09/19/1996CA2211669A1 6-substituted pyrazolo [3,4-d¦ pyrimidin-4-ones and compositions and methods of use thereof
09/19/1996CA2211326A1 Substituted n-arylmethyl and heterocyclylmethyl-1h-pyrazolo[3,4-b¦quinolin-4-amines and compositions and methods of use thereof
09/19/1996CA2211317A1 Substituted n-cycloalkylmethyl-1h-pyrazolo[3,4-b¦quinolin-4 amines and compositions and methods of use thereof
09/18/1996EP0732334A1 Piperidine derivatives, process for their preparation and their therapeutic application
09/18/1996EP0732333A1 Indazolecarboxamides
09/18/1996EP0732329A1 Chroman derivative
09/18/1996EP0732102A2 Composite for the treatment of acute myocardial infarction containing hirudin and acetylsalicyclic acid
09/18/1996EP0731803A1 Novel furanodiazepines
09/18/1996EP0731795A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
09/18/1996EP0731792A1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action
09/18/1996EP0731791A1 Novel benzenesulfonylimine derivatives as inhibitors of il-1 action
09/18/1996EP0731790A1 Tachykinin antagonists
09/18/1996EP0731787A1 Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
09/18/1996EP0731700A1 Medicament for treating heart insufficiency
09/18/1996EP0731697A1 Ssi tyrphostins and pharmaceutical compositions
09/18/1996EP0731696A1 Cysteine protease inhibitors containing heterocyclic leaving groups
09/18/1996EP0643780B1 Multiple solvent cleaning system
09/18/1996EP0588799B1 New sulphonamides, process for preparing the same and medicaments containing these compounds
09/18/1996CN1131438A Protein having TPO activity
09/18/1996CN1131437A Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
09/18/1996CN1131416A Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
09/18/1996CN1131415A Triaryl-ethylene derivatives for use in therapy
09/18/1996CN1131414A Aminoindanes and related compounds useful as calcium-channel antagonists
09/18/1996CN1131392A Nitric oxide donor composition and method for treatment of anal disorders
09/18/1996CN1131391A Use of thiazolidinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
09/18/1996CN1032815C Method for preparation of selective adenosine receptor agents
09/17/1996US5556990 Squalene synthase inhibitors, anticholesterol agents
09/17/1996US5556981 Angiotensin II antagonist intermediates
09/17/1996US5556876 Anticholesterol agents using derivatives of benzothienyl ketones
09/17/1996US5556870 Use of leflunomide for inhibiting interleukin 1 beta
09/17/1996US5556856 Anitarrhythmia, analgesics
09/17/1996US5556854 Cardiovascular disorders and/or neurogenerative disorders
09/17/1996US5556846 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene derivatives active on the cardiovascular system, and pharmaceutical compositions containing same
09/17/1996US5556845 11-β substituted-19-nor steroids
09/17/1996US5556843 Treatment of central nervous system disorders, inhibits activation of protein kinase c
09/17/1996US5556753 DNA encoding human α1 adrenegric receptors and uses thereof
09/16/1996CA2171509A1 Method of treating acute myocardial infarction with hirudin and acetylsalicylic acid in patients not undergoing thrombolytic treatment
09/14/1996CA2171579A1 Piperidine derivatives, process for the preparation thereof and application thereof in therapeutics
09/12/1996WO1996027608A1 Process for producing a protein
09/12/1996WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity
09/12/1996WO1996027583A1 Arylsulfonylamino hydroxamic acid derivatives
09/12/1996WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
09/12/1996WO1996027380A1 Reduction of infarct volume using citicoline
09/12/1996WO1996027372A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof
09/12/1996WO1996020718A3 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
09/12/1996CA2213000A1 Reduction of infarct volume using citicoline
09/12/1996CA2212125A1 Process for producing a protein
09/11/1996EP0731097A1 Novel benzofuran pharmaceutical compounds
09/11/1996EP0731093A1 Naphthyl pharmaceutical compounds
09/11/1996EP0730865A1 Use of serotonin and dopamine receptor blockers for the treatment of mental disorders associated with cerebrovascular disease
09/11/1996EP0730864A1 Medicament for treating cardiac inflammatory disease
09/11/1996EP0730651A1 Surface loop structural analogues of fibroblast growth factors
09/11/1996EP0730605A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
09/11/1996EP0730596A1 Benzodiazepines
09/11/1996EP0730590A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
09/11/1996EP0730589A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
09/11/1996EP0730584A1 3-acylaminobenzodiazepines
09/11/1996EP0730581A1 3-acylaminobenzazepines
09/11/1996EP0730571A1 Alpha-aryl or heteroaryl-substituted amide ester acat inhibitors
1 ... 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 ... 1595